Crossmark

Prognostic significance of pretreatment 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with T2N1 hormone receptor-positive, ERBB2-negative breast cancer who underwent adjuvant chemotherapy

Crossref DOI link: https://doi.org/10.1007/s10549-022-06852-5

Published Online: 2023-01-12

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Han, Sangwon

Lee, Sae Byul

Gong, Gyungyub

Lee, Jungbok

Chae, Sun Young

Oh, Jungsu S.

Moon, Dae Hyuk http://orcid.org/0000-0001-9892-4276
Funding

Funding for this research was provided by:

Ministry of Health and Welfare (HI18C2383)
License Information

Text and Data Mining valid from 2023-01-12

Version of Record valid from 2023-01-12
More Information

Article History

Received: 21 October 2022

Accepted: 26 December 2022

First Online: 12 January 2023

Declarations

:

: The authors declare no competing interests.

: This study was performed in line with the principles of the Declaration of Helsinki and was approved by the institutional review board of Asan Medical Center (2020-1648).

: The institutional review board of Asan Medical Center (2020-1648) waived the need for informed consent.

: The institutional review board of Asan Medical Center (2020-1648) approved publication of the study results to the research community.

Document is current

Any future updates will be listed below